Literature DB >> 22618200

Omega-6 docosapentaenoic acid-derived resolvins and 17-hydroxydocosahexaenoic acid modulate macrophage function and alleviate experimental colitis.

Cheng-Ying Chiu1, Beate Gomolka, Cordula Dierkes, Nora R Huang, Maik Schroeder, Martin Purschke, Dieter Manstein, Bindi Dangi, Karsten H Weylandt.   

Abstract

OBJECTIVE: Enzymatically oxygenated lipid products derived from omega-3 and omega-6 fatty acids play an important role in inflammation dampening. This study examined the anti-inflammatory effects of n-6 docosapentaenoic acid-derived (17S)-hydroxy-docosapentaenoic acid (17-HDPAn-6) and (10,17S)-dihydroxy-docosapentaenoic acid (10,17-HDPAn-6) as well as n-3 docosahexaenoic acid-derived 17(R/S)-hydroxy-docosahexaenoic acid (17-HDHA).
MATERIALS AND METHODS: The effects of 17-HDPAn-6, 10,17-HDPAn-6 or 17-HDHA on activity and M1/M2 polarization of murine macrophage cell line RAW 264.7 were examined by phagocytosis assay and real-time PCR. To assess anti-inflammatory effects in vivo, dextran sodium sulfate (DSS) colitis was induced in mice treated with 17-HDPAn-6, 10,17-HDPAn-6, 17-HDHA or NaCl.
RESULTS: Our results show that 17-HDPAn-6, 10,17-HDPAn-6 and 17-HDHA increase phagocytosis in macrophages in vitro and promote polarization towards the anti-inflammatory M2 phenotype with decreased gene expression of TNF-α and inducible Nitric oxide synthase and increased expression of the chemokine IL-1 receptor antagonist and the Scavenger receptor Type A. Intraperitoneal treatment with 17-HDPAn-6, 10,17-HDPAn-6, or 17-HDHA alleviated DSS-colitis and significantly improved body weight loss, colon epithelial damage, and macrophage infiltration.
CONCLUSION: These results suggest that DPAn-6-derived 17-HDPAn-6 and 10,17-HDPAn-6 as well as the DHA-derived 17-HDHA have inflammation-dampening and resolution-promoting effects that could be used to treat inflammatory conditions such as inflammatory bowel disease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22618200     DOI: 10.1007/s00011-012-0489-8

Source DB:  PubMed          Journal:  Inflamm Res        ISSN: 1023-3830            Impact factor:   4.575


  53 in total

Review 1.  Other functions, other genes: alternative activation of antigen-presenting cells.

Authors:  S Goerdt; C E Orfanos
Journal:  Immunity       Date:  1999-02       Impact factor: 31.745

Review 2.  Resolution of inflammation: the beginning programs the end.

Authors:  Charles N Serhan; John Savill
Journal:  Nat Immunol       Date:  2005-12       Impact factor: 25.606

Review 3.  Inflammatory bowel disease: cause and immunobiology.

Authors:  Daniel C Baumgart; Simon R Carding
Journal:  Lancet       Date:  2007-05-12       Impact factor: 79.321

Review 4.  Alternative activation of macrophages: an immunologic functional perspective.

Authors:  Fernando O Martinez; Laura Helming; Siamon Gordon
Journal:  Annu Rev Immunol       Date:  2009       Impact factor: 28.527

5.  Impaired phagocytosis in caveolin-1 deficient macrophages.

Authors:  Jiangwei Li; Alexis Scherl; Freddy Medina; Philippe G Frank; Richard N Kitsis; Herbert B Tanowitz; Federica Sotgia; Michael P Lisanti
Journal:  Cell Cycle       Date:  2005-11-23       Impact factor: 4.534

6.  High resolution colonoscopy in live mice.

Authors:  C Becker; M C Fantini; M F Neurath
Journal:  Nat Protoc       Date:  2006       Impact factor: 13.491

7.  A beta-oxidation-resistant lipoxin A4 analog treats hapten-induced colitis by attenuating inflammation and immune dysfunction.

Authors:  Stefano Fiorucci; John L Wallace; Andrea Mencarelli; Eleonora Distrutti; Giovanni Rizzo; Silvana Farneti; Antonio Morelli; Jih-Lie Tseng; Babu Suramanyam; William J Guilford; John F Parkinson
Journal:  Proc Natl Acad Sci U S A       Date:  2004-10-25       Impact factor: 11.205

8.  Resolvin E1-induced intestinal alkaline phosphatase promotes resolution of inflammation through LPS detoxification.

Authors:  Eric L Campbell; Christopher F MacManus; Douglas J Kominsky; Simon Keely; Louise E Glover; Brittelle E Bowers; Melanie Scully; Walter J Bruyninckx; Sean P Colgan
Journal:  Proc Natl Acad Sci U S A       Date:  2010-07-26       Impact factor: 11.205

9.  Resolvin E1 regulates interleukin 23, interferon-gamma and lipoxin A4 to promote the resolution of allergic airway inflammation.

Authors:  Oliver Haworth; Manuela Cernadas; Rong Yang; Charles N Serhan; Bruce D Levy
Journal:  Nat Immunol       Date:  2008-06-22       Impact factor: 25.606

10.  Chronic experimental colitis induced by dextran sulphate sodium (DSS) is characterized by Th1 and Th2 cytokines.

Authors:  L A Dieleman; M J Palmen; H Akol; E Bloemena; A S Peña; S G Meuwissen; E P Van Rees
Journal:  Clin Exp Immunol       Date:  1998-12       Impact factor: 4.330

View more
  25 in total

1.  Anger induced by interferon-alpha is moderated by ratio of arachidonic acid to omega-3 fatty acids.

Authors:  Francis E Lotrich; Barry Sears; Robert K McNamara
Journal:  J Psychosom Res       Date:  2013-07-26       Impact factor: 3.006

2.  Biosynthesis of proresolving lipid mediators by vascular cells and tissues.

Authors:  Anuran Chatterjee; Sevan Komshian; Brian E Sansbury; Bian Wu; Giorgio Mottola; Mian Chen; Matthew Spite; Michael S Conte
Journal:  FASEB J       Date:  2017-04-25       Impact factor: 5.191

Review 3.  The resolution code of acute inflammation: Novel pro-resolving lipid mediators in resolution.

Authors:  Charles N Serhan; Nan Chiang; Jesmond Dalli
Journal:  Semin Immunol       Date:  2015-04-07       Impact factor: 11.130

4.  Short-term n-3 fatty acid supplementation but not aspirin increases plasma proresolving mediators of inflammation.

Authors:  Anne Barden; Emilie Mas; Kevin D Croft; Michael Phillips; Trevor A Mori
Journal:  J Lipid Res       Date:  2014-09-03       Impact factor: 5.922

5.  Dietary n-3 PUFAs Deficiency Increases Vulnerability to Inflammation-Induced Spatial Memory Impairment.

Authors:  Jean-Christophe Delpech; Aurore Thomazeau; Charlotte Madore; Clementine Bosch-Bouju; Thomas Larrieu; Chloe Lacabanne; Julie Remus-Borel; Agnès Aubert; Corinne Joffre; Agnès Nadjar; Sophie Layé
Journal:  Neuropsychopharmacology       Date:  2015-05-07       Impact factor: 7.853

6.  Acute injection of a DHA triglyceride emulsion after hypoxic-ischemic brain injury in mice increases both DHA and EPA levels in blood and brain.

Authors:  Denny Joseph Manual Kollareth; Richard J Deckelbaum; Zequn Liu; Rajasekhar Ramakrishnan; Charlotte Jouvene; Charles N Serhan; Vadim S Ten; Hylde Zirpoli
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2020-09-25       Impact factor: 4.006

Review 7.  Effects of lithium on inflammation.

Authors:  Ahmad Nassar; Abed N Azab
Journal:  ACS Chem Neurosci       Date:  2014-05-06       Impact factor: 4.418

8.  Perturbations in blood phosphatidylcholine and sphingomyelin Fatty Acid composition in a sample population of cigarette smokers.

Authors:  Nicoleta Ionescu; Caterina de Freitas; Allain A Bueno
Journal:  Indian J Clin Biochem       Date:  2013-04-30

Review 9.  ω-3 polyunsaturated fatty acids-derived lipid metabolites on angiogenesis, inflammation and cancer.

Authors:  Weicang Wang; Julia Zhu; Fei Lyu; Dipak Panigrahy; Katherine W Ferrara; Bruce Hammock; Guodong Zhang
Journal:  Prostaglandins Other Lipid Mediat       Date:  2014-07-11       Impact factor: 3.072

10.  Maternal dietary omega-3 fatty acid intake increases resolvin and protectin levels in the rat placenta.

Authors:  Megan L Jones; Peter J Mark; Jeffrey A Keelan; Anne Barden; Emilie Mas; Trevor A Mori; Brendan J Waddell
Journal:  J Lipid Res       Date:  2013-05-30       Impact factor: 5.922

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.